Peer Review History: Overview of the Role of Glucagon like Peptide-1 Receptor Agonists in the Management of Polycystic Ovary Syndrome

Editor(s):

(1) Dr. S. Prabhu, Sri Venkateswara College of Engineering, India.

Reviewers:

(1) Athir Kadhim Mohammed, AL-Ma’moon University College, Iraq.

(2) Shasthara P, JSS Academy Of Higher Education and Research, India.

Additional Reviewers:

(1) Abrar Gomaa Abd Elfattah Hassan, Al Azhar Univiristy, Egypt.

(2) Monika Garg, Abvims & Dr Rml Hospital, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Athir Kadhim Mohammed, Iraq) | File 1 | File 2


Stage 2 | Peer review report_2 (Shasthara P, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Peer Review History: Impact of COVID-19 on Taste and Smell Sensation among Population in Western Region of Saudi Arabia

Editor(s):

(1) Prof.  John Yahya I. Elshimali, Professor, UCLA School of Medicine & Charles R. Drew University of Medicine and Science, USA.

(2) Dr. Dharmesh Chandra Sharma, G. R. Medical College & J. A. Hospital,  India.

Reviewers:

(1) Bruna Pereira Nagamine, Instituto Educacional Santa Catarina, Brazil.

(2) Bülent Bariş Güven, Sultan Abdulhamidhan Training and Research Hospital, Turkey.

(3) Dra Patricia Haas, Federal University of Santa Catarina, Brazil.

Additional Reviewers:

(1) Leticia Rosevics, Universidade Federal do Paraná, Brazil.

(2) Fernando Tortosa, Universidad Nacional de Rio Negro, Argentina.

(3) Alexander Ariel Padron Gonzalez, University of Paris, France.

(4) Demian Arturo Herrera Morban, Hospital Pediatrico Dr. Hugo Mendoza, Dominican Republic.

(5) Hazim Saad Jabbar Al-Maliki, College of Dentistry, University of Basrah, Iraq.

(6) Karla Ivohnne Pedraza Maquera, Jorge Basadre Grohmann University, Perú.

(7) Renato Satovschi Ginbaum, Universidade Cidade de São Paulo, Brazil.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.33/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Bruna Pereira Nagamine, Brazil) | File 1 | NA


Stage 2 | Peer review report_2 (Bülent Bariş Güven, Turkey) | File 1 | NA


Stage 2 | Peer review report_3 (Dra Patricia Haas, Brazil) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Peer Review History: Formulation Development of Novel Curcumin Analogue Loaded Non-aqueous Gel and Curcumin Analogue Loaded Nanoparticle (CA-NP) Gel for Topical Use and In-vitro Antioxidant Study

Editor(s):

(1) Dr. Mohamed Salem Nasr Allah, Assistant Professor, Weill Cornell Medical College, Qatar.

Reviewers:

(1) Deepika Bairagee, Oriental University, Indore, India.

(2) Shaik Firoz, Sree Vidyanikethan College of Pharmacy, India.

Additional Reviewers:

(1) Anita Sukmawati, Universitas Muhammadiyah Surakarta, Indonesia.

(2) Guler Bengusu Tezel, Turkey.

(3) Muhammed Basheer Ummathur, KAHM Unity Women’s College, India.

(4) Wilfrid Hinnoutondji Kpetehoto, University of Abomey-Calavi (UAC), Inter-Faculty Center for Environmental Training and Research for Sustainable Development (CIFRED), Benin.

(5) Mingxuan Xu, MD Anderson Cancer Center, USA.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Deepika Bairagee, India) | File 1 | NA


Stage 2 | Peer review report_2 (Shaik Firoz, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Influence of COVID-19 on Quality of Life among Nurses Treating COVID-19 in Tamil Nadu

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

(2) Dr. Mohamed Salem Nasr Allah, Assistant Professor, Weill Cornell Medical College, Qatar.

(3) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Abid Ulllah, Shaheed Benazir Bhutto University, Sheringal, Pakistan.

(2) Ana Vaz E De Braganca, Institute of Nursing Education, Goa, India.

Additional Reviewers:

(1) Endeshaw Chekol Abebe, Debre Tabor University, Ethiopia.

(2) Peter Ongwae, Maseno University, Kenya.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Abid Ulllah, Pakistan) | File 1 | File 2


Stage 2 | Peer review report_2 (Ana Vaz E De Braganca, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Stage 3 | Comment_Editor_3_v1 | File 1 | NA


 

Peer Review History: Case Report on Primary Infertility with Hypothyroidism and Diabetes Mellitus

Editor(s):

(1) Dr. Giulio Tarro, Professor & President, Foundation T. & L. de Beaumont Bonelli for cancer Research, Italy.

Reviewers:

(1) Mariyah Hidayat, University of Lahore, Pakistan.

(2) Pinar Yildiz, Eskisehir Osmangazi University, Turkey.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Mariyah Hidayat, Pakistan) | File 1 | NA


Stage 2 | Peer review report_2 (Pinar Yildiz, Turkey) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Cord Bilirubin Value as a Predictor of Significant Hyperbilirubinemia in Abo Incompatiblity

Editor(s):

(1) Amal Hegazi Ahmed Elrefaei, Division of Radioisotope Production,Hot Lab and Waste Management Center, Egypt.

Reviewers:

(1) Mahammad Rafi Shaik, Ntr University of Health Sciences, India.

(2) Gunvant Singh Eske, M.G.M. Medical College, India.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Mahammad Rafi Shaik, India) | File 1 | NA


Stage 2 | Peer review report_2 (Gunvant Singh Eske, India) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Covid Shielding (Preventive Measures of COVID-19)

Editor(s):

(1) Dr. Giuseppe Murdaca, University of Genoa, Italy.

(2) Dr. Syed A. A. Rizvi, Nova Southeastern University, USA.

Reviewers:

(1) Nawa Raj Subba, Purbanchal University, Nepal.

(2) Hasan Ekim, Bozok University, Turkey.

(3) Sourabh Radhakrishnan, Kerala University of Health Sciences, India.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.66/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Nawa Raj Subba, Nepal) | File 1 | NA


Stage 2 | Peer review report_2 (Hasan Ekim, Turkey) | File 1 | NA


Stage 2 | Peer review report_3 (Sourabh Radhakrishnan, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


 

Peer Review History: Oral Submucous Fibrosis – A Clinicopathological Correlation

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Nicola Marchili, Italy.

(2) Vijaya lakshmi G, The Tamil Nadu Dr. M.G.R. Medical University, India.

Additional Reviewers:

(1) Mutum Sangeeta Devi, Tata Medical Centre, India.

(2) S. P. Indra Kumar, Vivekanandha Dental College For Women, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Nicola Marchili, Italy) | File 1 | NA


Stage 2 | Peer review report_2 (Vijaya lakshmi G, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Three Distomolar in Single Patient: A Unique Case Report

Editor(s):

(1) Dr. Debarshi Kar Mahapatra, Assistant Professor, Rashtrasant Tukadoji Maharaj Nagpur University, India.

Reviewers:

(1) Jesus Luengo-Fereira, Universidad Autonoma de Zacatecas, Mexico.

(2) Philip Pradeep, Penang International Dental College, Malaysia.

(3) Tessho Maruyama, The University of the Ryukyus, Japan.

Additional Reviewers:

(1) A. J. Sai Sankar, Sibar Institute of Dental Sciences, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Jesus Luengo-Fereira, Mexico) | File 1 | NA


Stage 2 | Peer review report_2 (Philip Pradeep, Malaysia) | File 1 | NA


Stage 2 | Peer review report_3 (Tessho Maruyama, Japan) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Management Strategies for Oral Submucous Fibrosis- An Update

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.

Reviewers:

(1) Anshuman Jamdade, Mahatma Gandhi University of Medical Sciences and Technology, India.

(2) Chin-Mu Hsu, China Medical University, Taiwan.

(3) Hsi-feng Tu, National Yang-Ming University Hospital, Taiwan.

Additional Reviewers:

(1) Manoj Kumar Saurabh, Aii India Institute of Medical Sciences, India.

(2) Soumyadev Sarkar, Kansas State University, United States of America.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.33/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Anshuman Jamdade, India) | File 1 | File 2


Stage 2 | Peer review report_2 (Chin-Mu Hsu, Taiwan) | File 1 | NA


Stage 2 | Peer review report_3 (Hsi-feng Tu, Taiwan) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA